SEC Form 4 · accession 0001179110-18-012112

Tabula Rasa HealthCare, Inc. · TRHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Oct 8, 2018

Accepted (ET)

Oct 10, 2018 · 4:11 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001651561

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Oct 8, 2018	S	400	$71.25	D	859,499	D
Common Stock^F3	Oct 8, 2018	S	496	$72.10	D	859,003	D
Common Stock^F4	Oct 8, 2018	S	5,500	$74.35	D	853,503	D
Common Stock^F5	Oct 8, 2018	S	1,504	$75.10	D	851,999	D
Common Stock	Oct 8, 2018	S	100	$75.90	D	851,899	D
Common Stock	holding	—	—		—	843,351	I	Held by spouse.

No Table II lines on this filing.

F1This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2017.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.80 to $71.80, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $71.88 to $72.17, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $73.83 to $74.74, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $74.87 to $75.40, inclusive.